Adrenocortical Carcinoma Latest Advances

Unveiling PAK4 as a Key Biomarker in Adrenocortical Carcinoma: Insights from Bioinformatics and Experimental Evidence.

Journal: Archivos espanoles de urologia

Published: December 03, 2025

Rare but not forgotten: Therapeutic advancements for rare childhood cancers.

Journal: Molecular therapy. Oncology

Published: December 01, 2025

Oligometastatic adrenocortical carcinoma: definition and treatment.

Journal: Current opinion in oncology

Published: November 26, 2025

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Journal: Research square

Published: November 24, 2025

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Journal: Research square

Published: November 24, 2025

Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 23, 2025

Comparative Proteomic Profiling of Adrenocortical Neoplasia Using Mass Spectrometry.

Journal: Journal of proteome research

Published: November 21, 2025

Prevalence of Malignancy Among Incidental Indeterminate Adrenal Nodules on Contrast-Enhanced CT in Patients Without Known Cancer: A Multiinstitutional Study.

Journal: AJR. American journal of roentgenology

Published: November 19, 2025

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Journal: bioRxiv : the preprint server for biology

Published: November 19, 2025

Contemporary Approaches to Adrenocortical Carcinoma.

Journal: Hematology/oncology clinics of North America

Published: November 12, 2025

Advances in the diagnosis and treatment of adrenal cortex surgical diseases

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 11, 2025

Publisher Correction: Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy.

Journal: Scientific reports

Published: November 11, 2025

Filters

Unveiling PAK4 as a Key Biomarker in Adrenocortical Carcinoma: Insights from Bioinformatics and Experimental Evidence.

Unveiling PAK4 as a Key Biomarker in Adrenocortical Carcinoma: Insights from Bioinformatics and Experimental Evidence.

Rare but not forgotten: Therapeutic advancements for rare childhood cancers.

Rare but not forgotten: Therapeutic advancements for rare childhood cancers.

Oligometastatic adrenocortical carcinoma: definition and treatment.

Oligometastatic adrenocortical carcinoma: definition and treatment.

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.

Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].

Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].

Comparative Proteomic Profiling of Adrenocortical Neoplasia Using Mass Spectrometry.

Comparative Proteomic Profiling of Adrenocortical Neoplasia Using Mass Spectrometry.

Prevalence of Malignancy Among Incidental Indeterminate Adrenal Nodules on Contrast-Enhanced CT in Patients Without Known Cancer: A Multiinstitutional Study.

Prevalence of Malignancy Among Incidental Indeterminate Adrenal Nodules on Contrast-Enhanced CT in Patients Without Known Cancer: A Multiinstitutional Study.

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Contemporary Approaches to Adrenocortical Carcinoma.

Contemporary Approaches to Adrenocortical Carcinoma.

Advances in the diagnosis and treatment of adrenal cortex surgical diseases

Advances in the diagnosis and treatment of adrenal cortex surgical diseases

Publisher Correction: Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy.

Publisher Correction: Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy.